|Jump to:||Authorized Access|||||Attribution|||||Authorized Requests|
phs000642.v1.p1 : The Haplotype-Resolved Genome and Epigenome of The HeLa Cancer Cell Line phs000643.v1.p1 : The Genomic and Transcriptomic Landscape of a HeLa Cell Line
- Study Description
This study contains all authorized whole genome sequence data of the HeLa cell line from datasets currently in dbGaP. These data have been approved for health, medical, and/or biomedical research purposes. Access to these data can be granted for one year. Accessible data will include the studies listed on this page and any additional authorized datasets that become available during this one-year period.
- Study Design:
- Case Set
- Study Type:
- Whole Genome Sequencing
- Study Design:
- Authorized Access
- Publicly Available Data (Public ftp)
Connect to the public download site. The site contains release notes and manifests. The site also contains data dictionaries, variable summaries, documents, and truncated analyses, whenever available.
- Study History
HeLa is a human epithelial adenocarcinoma cell line that was derived from biopsy specimens of a 31-year old patient named Henrietta Lacks who was being treated for cervical cancer at The Johns Hopkins University Hospital in 1951. The specimens were obtained without her knowledge or consent just before her death in 1951. HeLa is the oldest and most widely used human cell line and has been an extraordinarily important resource for researchers throughout the world. HeLa cells have served as a standard for understanding many fundamental biological processes, such as testing the polio vaccine, establishing basic techniques for cloning and in vitro fertilization, identifying the cause of cervical cancer (HPV), and advancing the development of anti-cancer drugs.
- Selected publications
- Diseases/Traits Related to Study (MeSH terms)
- Primary Phenotype: Uterine Cervical Neoplasms
- Authorized Data Access Requests
- Study Attribution